In Focus

China's API supply disruption worries pharma companies

China's API supply disruption worries pharma companies

A bulk of drug intermediates are sourced from China.

In Focus

Asia Pacific healthtech funding crashed 27% to $4.95b in 2019

Healthtech investments in H2 slowed significantly.

In Focus

Philippines ramps up healthcare budget for 2020

The country’s government has allocated $3.2b to the health sector.

In Focus

PwC calls for public-private partnership for Singapore healthtech startups

Startups must be given access to clinical trials and early clinical input, it said.

In Focus

Challenges plague Asia's health tech assessment programmes

Solutions focus on improving HTAs’ integration to current drug pricing schemes.

In Focus

Hurdles persist in Southeast Asia's UHC push despite $160b healthcare spend

Universal healthcare still struggles to take off in Myanmar and the Philippines.

In Focus

Philippines sighted to spend $17.16b on healthcare

The approval of the universal healthcare bill is speeding up expenses in the country.

In Focus

Tokyo tops hospital city rankings

It got stellar scores for access and quality of care.

In Focus

Smart visa driven medical tourism boom threatens to overwhelm Thai public hospitals

About 1.4 million international patients received medical treatment in 2012.

In Focus

Can the Philippines implement national membership programmes in its UHC push?

The private sector can be tapped for its extensive expertise in delivering high-quality care.

In Focus

10 in 11 APAC healthcare groups saw negative shareholder returns in 2016-2018: Bain

Rising costs, evolving regulations and reimbursement pressure eroded profits.

In Focus

Asian healthtech deals hit $2.5b

$595m went to firms geared towards health management solutions.

In Focus

Migrant workers gain access to universal healthcare in Thailand

An estimated 1.5 million undocumented migrants registered with the Ministry of Public Health in 2018.

In Focus

New York-listed New Frontier to buy China's United Family Healthcare for $1.44b

UFH is expected to be given the exclusive right to manage New Frontier Group’s 64,000 sqm flagship Shenzhen city center hospital.

In Focus

APAC's medical device markets to be further hit by tighter regulations and pricing controls

Medical device approvals in China plunged 38% in 2018 to 5,528 successful registrations.

In Focus

Medical device FDIs to extend slump in 2020

India’s foreign investments into the sector crashed 60% in 2017 and 2018 down to $67m.

In Focus

Bumrungrad International Hospital shocks the market with $15 telemedicine consultations

New and existing patients can use Bumrungrad Anywhere to access over 200 doctors at the touch of an app.

In Focus